Something new in the treatment arsenal?
AstraZeneca reported positive results from a Phase 3 trial for a breast- cancer treatment, sending its American depositary receipts higher.
Shares of AstraZeneca (ticker: AZN) were up 1.7% to $68.16 in morning trading.
The company said the trial showed that the treatment, datopotamab deruxtecan, showed a significant improvement relative to chemotherapy in terms of progression-free survival. Plans to submit the drug for regulatory approval globally are underway.
Progression-free survival “is defined as the time from random assignment in a clinical trial to disease progression or death from any cause,” according to the National Library of Medicine.
Interested in more discussions like this? Go to the Breast Cancer Support Group.
Connect

🙏🏻🙏🏻🙏🏻
-
Like -
Helpful -
Hug
1 Reaction@einnoc - thank you for sharing the article. Here is the study that the article was based on to help provide more context on the science behind it, https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-23-1161/741920/Long-term-Multimodal-Recording-Reveals-Epigenetic.
-
Like -
Helpful -
Hug
4 ReactionsHi. I am happy to hear this. I currently have a fractured rib due to one lesion they have found in that spot. I was diagnosed in August with Mets to liver and lung. And now that one rib.
I have pain in that rib. I am hoping it’s from the fracture and not the lesion. To hear you had 7 areas it must be so painful !! I am worried about the bones.
-
Like -
Helpful -
Hug
6 ReactionsSoooo Happy for You! Great news for you and for all of us who may also need this treatment! Thank you for your generosity in sharing🌸
-
Like -
Helpful -
Hug
2 ReactionsYou’re are amazingly fighter. There is hope for all of us !!! 🙌🙏
-
Like -
Helpful -
Hug
1 ReactionYou are a warrior! You go girl! Your tenacity and bravery gives all of us hope!Many, many thanks to you for this wonderful gift and sharing this new strategy with us.
-
Like -
Helpful -
Hug
1 ReactionI'm so happy for you! Thank you for sharing this wonderful news with us!
(Quick question: The new progressions, were they all in bones?)
-
Like -
Helpful -
Hug
2 Reactions@leeann66
Wow, LeeAnn, that is truly amazing!!! I’m so happy for you! Thanks for the update.
-
Like -
Helpful -
Hug
1 ReactionGood morning, just a little update on my recent scan.
As a reminder I was diagnosed June 2020 de novo stage 4 breast cancer, HR+, HER2- (now considered HER2 low) Mets to bones in 7 places.
Kisqali and Anastrozole for 16 months, was NED then progression.
Also monthly XGeva injections which I still do.
Switched to Afinitor and Exemestane for about 6-8 weeks, had to stop due to bad rash and breathing trouble, continued disease progression.
Went on Xeloda for 6 months, didn’t work, continued disease progression.
Started the Tropion 01 clinical trial, phase 3, November 1, 2022.
Recent scan shows no sign of bones Mets, no sign of initial breast tumour, 3 lymph nodes still showing but have shrunk from initial scan and have remained the same size for last 6 months. Dr said it might actually be scar tissue and not cancer.
No new lesions or any evidence of disease elsewhere, all major organs continue to be clear!
Grateful for the Trial, Dato-Dxd and my medical team at the MUHC here in Montreal!!
-
Like -
Helpful -
Hug
27 Reactionshttps://www.icr.ac.uk/news-archive/research-uncovers-how-to-target-sleeping-breast-cancer-cells-and-prevent-relapse
-
Like -
Helpful -
Hug
3 Reactions